Lucid Diagnostics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Lucid Diagnostics Inc. (LUCD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 380.70 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 248.25K shares, a 19.40% increase year-over-year.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 132.44K shares, a 97.91% increase year-over-year.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 183.25K shares, a 26.56% increase year-over-year.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 197.50K shares, a 18.21% increase year-over-year.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 655.59K shares, a 11.63% increase from fiscal 2024.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 587.29K shares, a 13.51% decline from fiscal 2023.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 678.99K shares, a 167.82% increase from fiscal 2022.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 253.52K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 248.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 380.70K shares 10-Q · filed 2026-08-12 | 563.95K shares derived: sum of 3 quarters · filed 2026-08-12 | 761.45K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 132.44K shares 10-Q · filed 2026-05-13 | 315.69K shares derived: sum of 2 quarters · filed 2026-05-13 | 513.19K shares derived: sum of 3 quarters · filed 2026-05-13 | 721.11K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 183.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 380.75K shares derived: sum of 2 quarters · filed 2026-03-25 | 588.66K shares derived: sum of 3 quarters · filed 2026-03-25 | 655.59K shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 197.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 405.42K shares derived: sum of 2 quarters · filed 2025-11-12 | 472.34K shares 10-Q · filed 2025-11-12 | 617.13K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | 207.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 274.84K shares 10-Q · filed 2025-08-12 | 419.63K shares derived: sum of 3 quarters · filed 2026-03-25 | 586.71K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | 66.92K shares 10-Q · filed 2025-05-13 | 211.71K shares derived: sum of 2 quarters · filed 2026-03-25 | 378.79K shares derived: sum of 3 quarters · filed 2026-03-25 | 485.88K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | 144.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 311.87K shares derived: sum of 2 quarters · filed 2026-03-25 | 418.95K shares derived: sum of 3 quarters · filed 2026-03-25 | 587.29K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 167.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 274.16K shares derived: sum of 2 quarters · filed 2024-11-12 | 442.50K shares 10-Q · filed 2024-11-12 | 530.83K shares derived: sum of 4 quarters · filed 2025-03-24 |
| 2024-06-30 | 107.09K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 275.42K shares 10-Q · filed 2024-08-12 | 363.76K shares derived: sum of 3 quarters · filed 2025-03-24 | |
| 2024-03-31 | 168.34K shares 10-Q · filed 2024-05-13 | 256.67K shares derived: sum of 2 quarters · filed 2025-03-24 | ||
| 2023-12-31 | 88.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | 678.99K shares 10-K · filed 2025-03-24 | ||
| 2023-09-30 | 590.66K shares 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | 253.52K shares 10-K · filed 2024-03-25 | |||
| 2022-06-30 | 46.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 107.69K shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 60.93K shares 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |